Jérôme Haegeli, Group Chief Economist, Swiss Re Jérôme Haegeli,...
Category:
International News
Latest
Be wary of scams as Amazon Prime Day kicks off, experts warn
In updated guidance published last week, the Better Business Bureau...
Google in talks to buy Wiz in $23 billion cyber deal
The acquisition of Wiz could help Google catch up to Microsoft...
U.S. reverses stance, backs giving poorer countries access to COVID vaccine patents
Pharmaceutical companies working on vaccines have reported sharp revenue and profit gains during the crisis. The industry’s biggest lobby group warned that Biden’s unprecedented step would undermine the companies’ response to the pandemic and compromise safety.
EU seeks India’s support for plastics treaty, draft summit statement says
The draft statement said the EU and India would hold regular meetings to increase collaboration in areas including renewable energy, energy storage technology, and modernizing power grids. India aims to have 450 gigawatts (GW) of renewable energy generation capacity by 2030, roughly five times the 93GW it has today.
Germany aims for net zero emissions by 2045, 5 years early
The government was forced to rework its plans after Germany’s highest court ruled last week that existing legislation risks placing too much of a burden for curbing climate change on younger generations.
WTO mulling intellectual property waivers for vaccines
The argument, part of a long-running debate about intellectual property protections, centers on lifting patents, copyrights, and protections for industrial design and confidential information to help expand the production and deployment of vaccines during supply shortages. The aim is to suspend the rules for several years, just long enough to beat down the pandemic.
The issue has become more pressing with a surge in cases in India, the world’s second-most populous country and a key producer of vaccines, including one for Covid-19 that relies on technology from Oxford University and British-Swedish pharmaceutical maker AstraZeneca.
Debris from China space rocket likely to fall in international waters -Global Times
“All debris can be potential threats to spaceflight safety and the space domain,” the Pentagon said, adding that the 18th Space Control Squadron in California would be offering daily updates on the rocket body’s location from May 4. The White House said the United States was committed to addressing the risks of congestion due to space debris and wants to work with the international community “to promote leadership and responsible space behaviors.”
Markel Singapore appoints financial lines underwriter
Joe will underwrite a range of financial lines products, including Cyber, Commercial D&O, Professional Indemnity, Financial institutions, and Financial technology.
Pfizer lifts sales forecast for coronavirus vaccine to $26 billion
The raised goal assumes 1.6 billion doses of vaccine, which is co-developed with BioNTech SE, will be delivered in the year, with the two-shot vaccine emerging as the best-selling product for the U.S. drugmaker in the first quarter.
“Based on what we’ve seen, we believe that a durable demand for our COVID-19 vaccine – similar to that of the flu vaccines – is a likely outcome,” Chief Executive Albert Bourla said in his prepared remarks.
China directs 33 apps to stop collecting users’ data
The Cyberspace Administration of China (CAC) said in a statement on Saturday that these apps had breached local regulations, primarily, for capturing personal data that were not relevant to their service.
Warren Buffett says Greg Abel is his likely successor at Berkshire Hathaway
He also said that if anything happened to Abel, it would be Ajit Jain, who oversees Berkshire’s insurance businesses, would become chief executive, but Jain is about a decade older.
Waivers for vaccine production “not a solution” – BioNTech
Such waivers are among the options being considered by the Biden administration for maximising the production and supply of vaccines, though no decision has been made, White House press secretary Jen Psaki said on Tuesday. read more
“This is not a solution,” BioNTech CEO Ugur Sahin said.